BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30223933)

  • 1. Cardamonin protects against adverse cardiac remodeling through mTORC1 inhibition in mice with myocardial infarction.
    You W; Wu Z; Ye F; Wu X
    Pharmazie; 2018 Sep; 73(9):508-512. PubMed ID: 30223933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgolide A protects adverse cardiac remodeling through enhancing antioxidation and nitric oxide utilization in mice with pressure overload.
    You W; Wu Z; Ye F; Wu X
    Pharmazie; 2019 Nov; 74(11):698-702. PubMed ID: 31739841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy induced by cardamonin is associated with mTORC1 inhibition in SKOV3 cells.
    Shi D; Niu P; Heng X; Chen L; Zhu Y; Zhou J
    Pharmacol Rep; 2018 Oct; 70(5):908-916. PubMed ID: 30099297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice.
    Wu X; Cao Y; Nie J; Liu H; Lu S; Hu X; Zhu J; Zhao X; Chen J; Chen X; Yang Z; Li X
    Am J Pathol; 2013 Jun; 182(6):2005-14. PubMed ID: 23567640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine promotes angiogenesis and reduces cardiac hypertrophy in mice with myocardial infarction.
    Wu X; You W; Wu Z; Ye F; Chen S
    Anatol J Cardiol; 2018 Nov; 20(5):266-272. PubMed ID: 30391964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
    Savergnini SQ; Ianzer D; Carvalho MB; Ferreira AJ; Silva GA; Marques FD; Peluso AA; Beiman M; Cojocaru G; Cohen Y; Almeida AP; Rotman G; Santos RA
    PLoS One; 2013; 8(3):e57757. PubMed ID: 23469229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling.
    Singla DK; Lyons GE; Kamp TJ
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1308-14. PubMed ID: 17416601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.
    Buss SJ; Muenz S; Riffel JH; Malekar P; Hagenmueller M; Weiss CS; Bea F; Bekeredjian R; Schinke-Braun M; Izumo S; Katus HA; Hardt SE
    J Am Coll Cardiol; 2009 Dec; 54(25):2435-46. PubMed ID: 20082935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acacetin protects against cardiac remodeling after myocardial infarction by mediating MAPK and PI3K/Akt signal pathway.
    Chang W; Wu QQ; Xiao Y; Jiang XH; Yuan Y; Zeng XF; Tang QZ
    J Pharmacol Sci; 2017 Dec; 135(4):156-163. PubMed ID: 29276114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress.
    Yang Z; Wu QQ; Xiao Y; Duan MX; Liu C; Yuan Y; Meng YY; Liao HH; Tang QZ
    Oxid Med Cell Longev; 2018; 2018():4327901. PubMed ID: 30046377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling.
    Gao G; Chen W; Yan M; Liu J; Luo H; Wang C; Yang P
    Int J Mol Med; 2020 Jan; 45(1):195-209. PubMed ID: 31746373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 Inhibits Apoptosis Following MI and Induces Autophagy via mTORC1 Inhibition.
    Foglio E; Puddighinu G; Germani A; Russo MA; Limana F
    J Cell Physiol; 2017 May; 232(5):1135-1143. PubMed ID: 27580416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
    Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
    Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringa pinnatifolia Hemsl. fraction protects against myocardial ischemic injury by targeting the p53-mediated apoptosis pathway.
    Feng X; Zhang R; Li J; Cao Y; Zhao F; Du X; Gao X; Cao L; Chen S; Tu P; Chai X
    Phytomedicine; 2019 Jan; 52():136-146. PubMed ID: 30599893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway.
    Liu A; Gao X; Zhang Q; Cui L
    Mol Med Rep; 2013 Aug; 8(2):361-6. PubMed ID: 23732925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.
    Hennig M; Fiedler S; Jux C; Thierfelder L; Drenckhahn JD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28778941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
    Du M; Yang W; Schmull S; Gu J; Xue S
    Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.